Eco R1 Capital, LLC Bio Atla, Inc. Transaction History

Eco R1 Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.63 - $11.01 $8.58 Million - $12.4 Million	1,124,439 New	1,124,439 $9.28 Million
Q4 2021 Feb 14, 2022	SELL	$19.0 - $30.95 $950,000 - $1.55 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.02 - $35.16 $1.55 Million - $1.76 Million	50,000 New	50,000 $1.7 Million

24.8M

140K

4.6K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $47.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.